logo

Amyris (AMRS)



Trade AMRS now with
  Date
  Headline
11/8/2018 8:34:58 AM Amyris Further Expands Original Collaboration With Yifan Pharmaceutical
9/27/2018 8:34:25 AM Amyris Enters Into Extensive Collaboration Agreement With Yifan Pharma
8/30/2018 8:33:05 AM Amyris Gets Green Light For Commercial Sales Of Its New, Natural, Zero-Calorie Sweetener
8/17/2018 9:04:29 AM Amyris Reports Pricing Of Secondary Offering Of 7.65 Mln Shares By Certain Of Existing Stockholders At $6.25/Shr
7/2/2018 8:33:31 AM Amyris Closes On A $36 Mln Term Loan With Great American Capital Partners, LLC
6/26/2018 8:35:20 AM Amyris And BGI Agree To JV To Develop Products To Improve Human Health In Greater China
6/12/2018 8:47:01 AM Amyris Executes Agreement For A Significant Project Consortium In Europe
5/18/2018 8:31:28 AM Amyris JV Company, Novvi, And Chevron Enter Agreement To Develop And Bring To Market New Renewable Base Oil Tech
5/3/2018 8:36:10 AM Amyris Partners With Fragrance Partner, Firmenich, To Support Development, Commercialization Of Z11
1/25/2018 2:17:32 PM B. Riley FBR Initiates Amyris (AMRS) At Buy With $8 Price Target
8/1/2012 8:25:25 AM Robert W. Baird Reiterates Amyris (AMRS) At Neutral With $2 Price Target
8/1/2012 7:34:57 AM Robert W. Baird Is Cutting Amyris (AMRS) FY12 Estimate To -2.70 From -2.32
8/1/2012 7:34:38 AM Robert W. Baird Is Cutting Amyris (AMRS) FY13 Estimate To -1.7000 From -1.0300
5/9/2012 8:24:32 AM Robert W. Baird Reiterates Amyris (AMRS) At Neutral With $2 Price Target
5/9/2012 7:35:16 AM Robert W. Baird Is Cutting Amyris (AMRS) FY13 Estimate To -1.03 From -0.95
5/9/2012 7:34:45 AM Robert W. Baird Is Cutting Amyris (AMRS) FY12 Estimate To -2.32 From -1.65